These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 34576302)

  • 1. Brain Renin-Angiotensin System as Novel and Potential Therapeutic Target for Alzheimer's Disease.
    Loera-Valencia R; Eroli F; Garcia-Ptacek S; Maioli S
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin-Angiotensin System and Alzheimer's Disease Pathophysiology: From the Potential Interactions to Therapeutic Perspectives.
    Ribeiro VT; de Souza LC; Simões E Silva AC
    Protein Pept Lett; 2020; 27(6):484-511. PubMed ID: 31886744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research Progress of Alzheimer's Disease Therapeutic Drugs: Based on Renin-Angiotensin System Axis.
    Li X; Xuan W; Chen D; Gao H; Wang G; Guo Q; Wang Y; Song H; Cai B
    J Alzheimers Dis; 2020; 78(4):1315-1338. PubMed ID: 33164932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain angiotensin II and angiotensin IV receptors as potential Alzheimer's disease therapeutic targets.
    Royea J; Hamel E
    Geroscience; 2020 Oct; 42(5):1237-1256. PubMed ID: 32700176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Renin-Angiotensin System and the Neurodegenerative Diseases: A Brief Review.
    Almeida-Santos AF; Kangussu LM; Campagnole-Santos MJ
    Protein Pept Lett; 2017 Nov; 24(9):841-853. PubMed ID: 28828974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of Renin-Angiotensin System May Slow Conversion from Mild Cognitive Impairment to Alzheimer's Disease.
    Wharton W; Goldstein FC; Zhao L; Steenland K; Levey AI; Hajjar I
    J Am Geriatr Soc; 2015 Sep; 63(9):1749-56. PubMed ID: 26389987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensins in Alzheimer's disease - friend or foe?
    Kehoe PG; Miners S; Love S
    Trends Neurosci; 2009 Dec; 32(12):619-28. PubMed ID: 19796831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The renin-angiotensin system, hypertension and cognitive dysfunction in Alzheimer's disease: new therapeutic potential.
    Takeda S; Sato N; Ogihara T; Morishita R
    Front Biosci; 2008 Jan; 13():2253-65. PubMed ID: 17981707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin and Alzheimer's disease: therapeutic prospects.
    Gard PR; Rusted JM
    Expert Rev Neurother; 2004 Jan; 4(1):87-96. PubMed ID: 15853619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of renin-angiotensin system-targeting antihypertensive drugs on treatment of Alzheimer's disease: a meta-analysis.
    Ye R; Hu Y; Yao A; Yang Y; Shi Y; Jiang Y; Zhang J
    Int J Clin Pract; 2015 Jun; 69(6):674-81. PubMed ID: 25721930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Connecting the brain cholesterol and renin-angiotensin systems: potential role of statins and RAS-modifying medications in dementia.
    Petek B; Villa-Lopez M; Loera-Valencia R; Gerenu G; Winblad B; Kramberger MG; Ismail MA; Eriksdotter M; Garcia-Ptacek S
    J Intern Med; 2018 Dec; 284(6):620-642. PubMed ID: 30264910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contributions by the Brain Renin-Angiotensin System to Memory, Cognition, and Alzheimer's Disease.
    Wright JW; Harding JW
    J Alzheimers Dis; 2019; 67(2):469-480. PubMed ID: 30664507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer's (HEART) Trial.
    Wharton W; Goldstein FC; Tansey MG; Brown AL; Tharwani SD; Verble DD; Cintron A; Kehoe PG
    J Alzheimers Dis; 2018; 61(2):815-824. PubMed ID: 29254080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of renin-aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease.
    Ashby EL; Kehoe PG
    Expert Opin Investig Drugs; 2013 Oct; 22(10):1229-42. PubMed ID: 23800077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-angiotensin system blockers affect cognitive decline and serum adipocytokines in Alzheimer's disease.
    Furiya Y; Ryo M; Kawahara M; Kiriyama T; Morikawa M; Ueno S
    Alzheimers Dement; 2013 Sep; 9(5):512-8. PubMed ID: 23142434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Angiotensin converting enzyme and Alzheimer's disease].
    Kugaevskaia EV
    Biomed Khim; 2013; 59(1):5-24. PubMed ID: 23650720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The brain RAS and Alzheimer's disease.
    Wright JW; Harding JW
    Exp Neurol; 2010 Jun; 223(2):326-33. PubMed ID: 19782074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol as a Natural Autophagy Regulator for Prevention and Treatment of Alzheimer's Disease.
    Kou X; Chen N
    Nutrients; 2017 Aug; 9(9):. PubMed ID: 28837083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the brain renin-angiotensin system in neurodegenerative disorders.
    Savaskan E
    Curr Alzheimer Res; 2005 Jan; 2(1):29-35. PubMed ID: 15977987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin as a target for the treatment of Alzheimer's disease, anxiety and depression.
    Gard PR
    Expert Opin Ther Targets; 2004 Feb; 8(1):7-14. PubMed ID: 14996614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.